November 21, 2009
Genzyme invites the Gaucher, Fabry, Pompe and MPS I communities to a Town Hall Meeting
Genzyme Manufacturing Update Genzyme invites all patients to participate in a forum to discuss recent FDA reports and media attention
November 17, 2009
November 2009 Pompe Program Update from Genzyme
Genzyme would like to provide an update to the US Pompe community about the status of the application for Lumizyme™
October 1, 2009
Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease
CRANBURY, N.J., Sept 30, 2009 – – Amicus Therapeutics today announced it plans to initiate a Phase 1 study of
July 23, 2009
Genzyme’s Second Quarter Earnings Statement
In their second quarter earning statement, Genzyme provided an update on the situation at the Allston manufacturing plant, and the
CAMBRIDGE, Mass. – Genzyme Corporation (Nasdaq: GENZ) announced today that it has submitted the final documentation to address all items